Found: 13
Select item for more details and to access through your institution.
Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Single-Dose Safety, Pharmacology, and Antiviral Activity of the Human...
- Published in:
- Journal of Infectious Diseases, 2000, v. 182, n. 1, p. 326, doi. 10.1086/315698
- By:
- Publication type:
- Article
A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0063818
- By:
- Publication type:
- Article
T cell profiling reveals high CD4CTLA-4 T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 245, doi. 10.1007/s00262-012-1330-5
- By:
- Publication type:
- Article
Tumor-reprogrammed resident T cells resist radiation to control tumors.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-11906-2
- By:
- Publication type:
- Article
A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma.
- Published in:
- Sarcoma, 2013, p. 1, doi. 10.1155/2013/168145
- By:
- Publication type:
- Article
Clinical outcomes among unresectable, locally advanced, and metastatic cutaneous squamous cell carcinoma patients treated with systemic therapy.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 20, p. 7381, doi. 10.1002/cam4.3146
- By:
- Publication type:
- Article
Sequence of αPD-1 relative to local tumor irradiation determines the induction of abscopal antitumor immune responses.
- Published in:
- Science Immunology, 2021, v. 6, n. 58, p. 1, doi. 10.1126/sciimmunol.abg0117
- By:
- Publication type:
- Article
Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and Granulocyte Macrophage Colony‐Stimulating Factor in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1508, doi. 10.1002/onco.13810
- By:
- Publication type:
- Article
Anti‐Hu‐Associated Autoimmune Limbic Encephalitis in a Patient with PD‐1 Inhibitor‐Responsive Myxoid Chondrosarcoma.
- Published in:
- Oncologist, 2018, v. 23, n. 1, p. 118, doi. 10.1634/theoncologist.2017-0344
- By:
- Publication type:
- Article
An open-label, multiple ascending dose study of the anti-CTLA-4 antibody ipilimumab in viremic HIV patients.
- Published in:
- PLoS ONE, 2018, v. 13, n. 6, p. 1, doi. 10.1371/journal.pone.0198158
- By:
- Publication type:
- Article
Fixed Dose of Cemiplimab in Patients with Advanced Malignancies Based on Population Pharmacokinetic Analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article